{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:07:25Z","timestamp":1790690845342,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008386","name":"Marmara University","doi-asserted-by":"publisher","award":["TYL-2024-11233"],"award-info":[{"award-number":["TYL-2024-11233"]}],"id":[{"id":"10.13039\/501100008386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.compbiomed.2025.110498","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T14:31:11Z","timestamp":1749479471000},"page":"110498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The anti-angiogenic and cytotoxic potential of different Eremurus spectabilis fractions on hepatocellular carcinoma (Hep3B) cells: An in vitro, in Ovo, and in silico study"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2972-5005","authenticated-orcid":false,"given":"Nour","family":"Alhalak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-5741","authenticated-orcid":false,"given":"Ali","family":"\u015een","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-3984","authenticated-orcid":false,"given":"Gamze Nur","family":"\u00d6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-2034","authenticated-orcid":false,"given":"Remzi Okan","family":"Akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4875-5472","authenticated-orcid":false,"given":"Engin","family":"Ulukaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3120-2911","authenticated-orcid":false,"given":"Turgut","family":"\u015eekerler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.110498_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.601710","article-title":"Etiology of hepatocellular carcinoma: special focus on fatty liver disease","volume":"10","author":"Suresh","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110498_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5009\/gnl15257","article-title":"Epidemiology of hepatocellular carcinoma in the Asia-Pacific region","volume":"10","author":"Zhu","year":"2016","journal-title":"Gut and liver"},{"issue":"S4","key":"10.1016\/j.compbiomed.2025.110498_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110498_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110498_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.719896","article-title":"Advances of targeted therapy for hepatocellular carcinoma","volume":"11","author":"Niu","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110498_bib6","first-page":"1943","article-title":"Effect of Derris scandens extract on a human hepatocellular carcinoma cell line","volume":"16","author":"Kuljittichanok","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110498_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jhep.2004.09.006","article-title":"Angiogenesis and hepatocellular carcinoma","volume":"41","author":"Semela","year":"2004","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110498_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.510300509","article-title":"KDR\/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells","volume":"30","author":"Yoshiji","year":"1999","journal-title":"Hepatology (Baltim., Md.)"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110498_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biology & Medicine"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110498_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.compbiomed.2025.110498_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2394-5079.167378","article-title":"Effects of natural compounds in treatment and prevention of hepatotoxicity and hepatocellular carcinoma","volume":"1","author":"Hamzawy","year":"2015","journal-title":"Hepatoma Research"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110498_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.26650\/EurJBiol.2021.1028656","article-title":"Antioxidant activities of Eremurus spectabilis M. Bieb. Extracts and sulfur compounds","volume":"80","author":"Bayrak","year":"2021","journal-title":"Euro. J. Biol."},{"key":"10.1016\/j.compbiomed.2025.110498_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.phytol.2022.12.002","article-title":"A comprehensive review on Eremurus species: phytochemistry, pharmacology and traditional uses","volume":"53","author":"Farhadi","year":"2023","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.compbiomed.2025.110498_bib15","first-page":"1","article-title":"Absolute configurations of biantraquinones from Eremurus spectabilis BIEB","author":"Koldas","year":"2023","journal-title":"Nat. Prod. Res."},{"issue":"15","key":"10.1016\/j.compbiomed.2025.110498_bib16","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1080\/14786419.2017.1292268","article-title":"Chemical constituents and in vitro biological activities of Eremurus spectabilis leaves","volume":"31","author":"Karakaya","year":"2017","journal-title":"Nat. Prod. Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110498_bib17","first-page":"4787","article-title":"Antioxidant, antimicrobial and anticancer effects of different extracts from wild edible plant Eremurus spectabilis leaves and roots","volume":"10","author":"Tuzcu","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110498_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.21448\/ijsm.510316","article-title":"Antioxidant and anti-inflammatory activity of capitula, leaf and stem extracts of Tanacetum cilicicum (Boiss.) Grierson","volume":"6","author":"Y\u0131ld\u0131r\u0131m","year":"2019","journal-title":"Int. J. Secondary Metabol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110498_bib22","doi-asserted-by":"crossref","DOI":"10.12991\/mpj.2018.54","article-title":"Evaluation of anti-proliferative and cytotoxic effects of chlorogenic acid on breast cancer cell lines by real-time, label-free and high-throughput screening","volume":"22","author":"Bender","year":"2018","journal-title":"Marmara Pharm. J."},{"key":"10.1016\/j.compbiomed.2025.110498_bib23","series-title":"Natural Compounds in Cancer Therapy","author":"Boik","year":"2001"},{"issue":"15","key":"10.1016\/j.compbiomed.2025.110498_bib24","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.3390\/molecules27154989","article-title":"In vitro cytotoxic activity of african plants: a review","volume":"27","author":"Canga","year":"2022","journal-title":"Molecules (Basel)"},{"issue":"57","key":"10.1016\/j.compbiomed.2025.110498_bib25","doi-asserted-by":"crossref","first-page":"35806","DOI":"10.1039\/D1RA05686G","article-title":"Journey of anthraquinones as anticancer agents\u2013a systematic review of recent literature","volume":"11","author":"Malik","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2025.110498_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-817903-1.00003-6","article-title":"Anticancer activity of natural coumarins for biological targets","volume":"64","author":"\u00d6nder","year":"2020","journal-title":"Stud. Nat. Prod. Chem."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110498_bib27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1517\/13543784.2012.727395","article-title":"Terpenoids: natural products for cancer therapy","volume":"21","author":"Huang","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110498_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/med.10033","article-title":"Flavonoids: promising anticancer agents","volume":"23","author":"Ren","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110498_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/hep.29033","article-title":"Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism","volume":"66","author":"Lin","year":"2017","journal-title":"Hepatology (Baltim., Md.)"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110498_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cbi.2011.03.013","article-title":"Rhein inhibits angiogenesis and the viability of hormone-dependent and-independent cancer cells under normoxic or hypoxic conditions in vitro","volume":"192","author":"Fernand","year":"2011","journal-title":"Chem. Biol. Interact."},{"issue":"1\u20133","key":"10.1016\/j.compbiomed.2025.110498_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2006.09.026","article-title":"Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1\/2 phosphorylation","volume":"553","author":"Kaneshiro","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110498_bib32","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.21641","article-title":"Emodin inhibits vascular endothelial growth factor\u2010A\u2010induced angiogenesis by blocking receptor\u20102 (KDR\/Flk\u20101) phosphorylation","volume":"118","author":"Kwak","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110498_bib33","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/antiox12051101","article-title":"Danthron, an anthraquinone isolated from a marine fungus, is a new inhibitor of angiogenesis exhibiting interesting antitumor and antioxidant properties","volume":"12","author":"Vidal","year":"2023","journal-title":"Antioxidants"},{"issue":"23","key":"10.1016\/j.compbiomed.2025.110498_bib34","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.3390\/molecules24234278","article-title":"Antiangiogenic effects of coumarins against cancer: from chemistry to medicine","volume":"24","author":"Majnooni","year":"2019","journal-title":"Molecules (Basel)"},{"issue":"10","key":"10.1016\/j.compbiomed.2025.110498_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/13880209.2011.559476","article-title":"Inhibition of tumor progression by naturally occurring terpenoids","volume":"49","author":"Kuttan","year":"2011","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.compbiomed.2025.110498_bib36","article-title":"Natural products targeting tumour angiogenesis","author":"Lu","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110498_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ijms19010027","article-title":"Antiangiogenic effect of flavonoids and chalcones: an update","volume":"19","author":"Mirossay","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.110498_bib38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2017.09.004","article-title":"Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells","volume":"265","author":"Spigoni","year":"2017","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110498_bib39","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ncb873","article-title":"Membrane microviscosity regulates endothelial cell motility","volume":"4","author":"Ghosh","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.compbiomed.2025.110498_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-006-9046-9","article-title":"Inhibition of laminin-8 in vivo using a novel poly (malic acid)-based carrier reduces glioma angiogenesis","volume":"9","author":"Fujita","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1016\/j.compbiomed.2025.110498_bib41","doi-asserted-by":"crossref","DOI":"10.2147\/CCID.S389760","article-title":"Effect of azelaic acid on psoriasis progression investigated based on phosphatidylinositol 3-kinase (PI3K)\/Protein kinase B (AKT) signaling pathway","author":"Li","year":"2022","journal-title":"Clin. Cosmet. Invest. Dermatol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525008492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525008492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:21:02Z","timestamp":1790688062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525008492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"alternative-id":["S0010482525008492"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110498","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-angiogenic and cytotoxic potential of different Eremurus spectabilis fractions on hepatocellular carcinoma (Hep3B) cells: An in vitro, in Ovo, and in silico study","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110498"}}